Determine the necessary mass, volume, or concentration for preparing a solution.
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
SKU | Size | Availability | Price | Qty |
---|---|---|---|---|
P276510-1mg | 1mg | Available within 8-12 weeks(?) Production requires sourcing of materials. We appreciate your patience and understanding. | $34.90 | |
P276510-5mg | 5mg | In stock | $141.90 | |
P276510-10mg | 10mg | In stock | $224.90 | |
P276510-25mg | 25mg | In stock | $450.90 | |
P276510-50mg | 50mg | In stock | $652.90 | |
P276510-100mg | 100mg | In stock | $1,044.90 | |
P276510-250mg | 250mg | In stock | $2,351.90 |
Small molecule inhibitor of PD-1/PD-L1 interaction
Synonyms | (2S)-1-[[2,6-dimethoxy-4-[(2-methyl-3-phenylphenyl)methoxy]phenyl]methyl]piperidine-2-carboxylicacid;(S)-1-(2,6-dimethoxy-4-((2-methyl-[1,1'-biphenyl]-3-yl)methoxy)benzyl)piperidine-2-carboxylic acid;PD1-PDL1-IN1;BMS-1 |
---|---|
Specifications & Purity | ≥98% |
Biochemical and Physiological Mechanisms | In the cell-free HTRF test, PD-1/PD-L1 inhibitor 1 blocked the PD-1/PD-L1 interaction with an IC50 of 6 nM. |
Storage Temp | Store at -20°C |
Shipped In | Ice chest + Ice pads |
Product Description | Shipped at 4°C. Store at -20°C. |
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
IUPAC Name | (2S)-1-[[2,6-dimethoxy-4-[(2-methyl-3-phenylphenyl)methoxy]phenyl]methyl]piperidine-2-carboxylic acid |
---|---|
INCHI | InChI=1S/C29H33NO5/c1-20-22(12-9-13-24(20)21-10-5-4-6-11-21)19-35-23-16-27(33-2)25(28(17-23)34-3)18-30-15-8-7-14-26(30)29(31)32/h4-6,9-13,16-17,26H,7-8,14-15,18-19H2,1-3H3,(H,31,32)/t26-/m0/s1 |
InChi Key | ZBOYJODMIAUJHH-SANMLTNESA-N |
Canonical SMILES | CC1=C(C=CC=C1C2=CC=CC=C2)COC3=CC(=C(C(=C3)OC)CN4CCCCC4C(=O)O)OC |
Isomeric SMILES | CC1=C(C=CC=C1C2=CC=CC=C2)COC3=CC(=C(C(=C3)OC)CN4CCCC[C@H]4C(=O)O)OC |
PubChem CID | 91663303 |
Molecular Weight | 475.6 |
Enter Lot Number to search for COA:
To view the certificate results,please click on a Lot number.For Lot numbers from past orders,please use our order status section
Lot Number | Certificate Type | Date | Item |
---|---|---|---|
A2429378 | Certificate of Analysis | Feb 18, 2024 | P276510 |
K2216702 | Certificate of Analysis | Sep 13, 2023 | P276510 |
K2216749 | Certificate of Analysis | Sep 13, 2023 | P276510 |
K2216772 | Certificate of Analysis | Sep 13, 2023 | P276510 |
K2216833 | Certificate of Analysis | Sep 13, 2023 | P276510 |
K2216834 | Certificate of Analysis | Sep 13, 2023 | P276510 |
K2216835 | Certificate of Analysis | Sep 13, 2023 | P276510 |
K2216773 | Certificate of Analysis | Oct 17, 2022 | P276510 |
Solubility | 200 mM in DMSO 200 mM in water 200 mM in ethanol;insoluble in H2O; insoluble in EtOH; ≥5.98 mg/mL in DMSO with gentle warming and ultrasonic |
---|
Pictogram(s) | GHS07 |
---|---|
Signal | Warning |
Hazard Statements | H315:Causes skin irritation H319:Causes serious eye irritation H335:May cause respiratory irritation H302:Harmful if swallowed |
Precautionary Statements | P261:Avoid breathing dust/fume/gas/mist/vapors/spray. P305+P351+P338:IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses if present and easy to do - continue rinsing. |
Starting at $75.90
1. Xia W et al.. (2020) PD-L1 Inhibitor Regulates the miR-33a-5p/PTEN Signaling Pathway and Can Be Targeted to Sensitize Glioblastomas to Radiation.. Front Oncol, 10 (821). [PMID:32537433] |
2. Zhang G. (2022) Regulatory T-cells-related signature for identifying a prognostic subtype of hepatocellular carcinoma with an exhausted tumor microenvironment.. Front Immunol, 13 (975762). [PMID:36189226] |
3. Yun T et al.. (2020) Significance of Detection of the HER2 Gene and PD-1/PD-L1 in Gastric Cancer.. J Oncol, 2020 (8678945). [PMID:33123197] |